| ¿µ¹® | tissue biopsy | ÇÑ±Û | Á¶Á÷»ý°Ë |
|---|---|---|---|
| ¼³¸í | ȯÀÚÀÇ º´ÀûÀÎ Á¶Á÷ÀÇ ÀϺθ¦ ¶¼¾î ³»¼ º´¸®Á¶Á÷Ç¥º»À» ¸¸µé¾î¼ Çö¹Ì°æÀûÀ¸·Î °Ë»çÇÏ´Â °Í. ¿Ü°úÀû ¼ö¼úÀç·á·ÎºÎÅÍ º´¸®Á¶Á÷ÇÐÀû °Ë»ç¸¦ ÇÏ¿© »ýü³»ÀÇ º´º¯À» Ãß±¸ÇÏ´Â ºÐ¾ß¸¦ ¿Ü°úº´¸®ÇÐÀ̶ó°í ÇÑ´Ù. »ý°Ë¿¡´Â ½û±â»ý°Ë, õÀÚħ»ý°Ë, ²ç¶Õ±â½Ä»ý°Ë, ³»½Ã°æ»ý°Ë ¿Ü¿¡ ¼¼Æ÷ÁøÀ̶ó°í ºÒ¸®¿ì´Â ¹Ú¸®¼¼Æ÷ÁøÀ̳ª ¼¼Ã´¼¼Æ÷Áø µî ¶³¾îÁø ¼¼Æ÷¸¦ µµ¸»°Ë»çÇÏ´Â ¹æ¹ýÀÌ Æ÷ÇԵȴÙ. |
||
| ¿µ¹® | target tissue | ÇÑ±Û | Ç¥ÀûÁ¶Á÷ |
|---|---|---|---|
| ¼³¸í | È£¸£¸ó¿¡ ´ëÇÏ¿© Ç¥ÀûÀÌ µÇ´Â ¼¼Æ÷¶ó´Â Àǹ̷μ ±× È£¸£¸ó¿¡ ´ëÇÑ ¼ö¿ëü¸¦ °¡Áö°í ÀÖ´Â ¼¼Æ÷. ¿¹¸¦ µé¾î Àν¶¸°Àº Àν¶¸° ¼ö¿ëü¸¦ °¡Áø ¼¼Æ÷¸¦ Ç¥Àû¼¼Æ÷·Î ÇÏ¿© ÀÌ ¼¼Æ÷¿¡¸¸ ÀÛ¿ëÇÑ´Ù. |
||
| ¿µ¹® | subcutaneous tissue, subcutis | ÇÑ±Û | ÇÇÇÏÁ¶Á÷ |
|---|---|---|---|
| ¼³¸í | ÇǺο¡¼ ÁøÇÇÀÇ ¾Æ·§ºÎºÐÀ» ¸»ÇÔ. ¿©±â¿¡´Â Áö¹æÁ¶Á÷ÀÌ ¸¹´Ù. ±â´ÉÀº ¿ÀÇ °Ý¸®, Ãæ°ÝÈí¼ö, ¿µ¾çÀúÀå¼Ò µîÀÌ´Ù. |
||
| GDXY | XY gonadal dysgenesis |
|---|---|
| GSBG | gonadal steroid-binding globulin |
| MGD | maximal glucose disposal; mixed gonadal dysgenesis |
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
| TCID | tissue culture infective dose; tissue culture inoculated dose |
| gonadal dysgenesis | <embryology, genetics> A rare genetic disorder in women that is characterised by the absence of an X chromosome. This disorder inhibits normal sexual development and causes infertility. Features include webbing of the neck, short stature, retarded development of secondary sex characteristics, absence of menses, coarctation of the aorta, low hairline, eye abnormalities (drooping eyelids) and skeletal deformities. Treatment include oestrogen supplementation at puberty. Growth hormone replacement may be necessary in some cases. Cardiac surgery may be necessary to correct coarctation of the aorta. Incidence: 1 in 3,000 births. (10 Oct 1997) |
|---|---|
| gonadal dysgenesis, 46,xy | A syndrome characterised by "streak gonads" in a phenotypic female with a 46,xy karyotype. It is due to a mutation which inhibits the function of the y-borne determinant that would normally cause the indifferent embryonic gonad to differentiate into a testis. The streak gonad is incapable of ovulation or oestrogen secretion. The syndrome is sometimes called "pure gonadal dysgenesis," but this designation may also refer to the presence of streak gonads with a 46,xx karyotype. (12 Dec 1998) |
| gonadal dysgenesis, mixed | A syndrome of gonadal dysgenesis in which there is a testis on one side and a "streak gonad" on the other. The phenotype is generally male, but may be female since the individual is a mosaic. Various karyotypes have been identified, including 45,xo/47,xyy; 45,xo/46,xy; and 45,xo/46,xyo. (12 Dec 1998) |
| gonadal hormones | Hormones having oestrogenic (female sex hormones) or androgenic (male sex hormones) activity. (12 Dec 1998) |
| gonadal ridge | An elevation of thickened mesothelium and underlying mesenchyme on the ventromedial border of the embryonic mesonephros; the primordial germ cells become embedded in it, establishing it as the primordium of the testis or ovary. Synonym: genital ridge. (05 Mar 2000) |
| gonadal steroid-binding globulin | A protein that transports 65% of the testosterone in plasma. Synonym: sex steroid-binding globulin. (05 Mar 2000) |
| gonadal streak | A form of aplasia in which the ovary is replaced by a functionless tissue, as found in Turner's syndrome. Synonym: streak gonad. (05 Mar 2000) |
| sex reversal, gonadal | Change from one sex to another with regard to gonadal development; may be induced or occurs naturally in some invertebrates. (12 Dec 1998) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |
| vascular neoplasms | <oncology> Neoplasms located in vascular tissue or specific veins. They are differentiated from neoplasms, vascular tissue which are neoplasms composed of vascular tissue, such as angiofibroma or haemangioma. (12 Dec 1998) |
| pancreatic cystic neoplasms | <radiology> Microcystic adenoma, glycogen, benign, mucinous cystic neoplasm, macrocystic adenoma, cystadenoma/cystadenocarcinoma, mucin, pre-malignant, Both occur more commonly in women, peak in middle age (12 Dec 1998) |
| pancreatic neoplasms | <radiology> Adenocarcinoma, most common, usually in pancreatic head, nasty (1-2% survival at 1 yr!), cystic neoplasms, slow-growing, more common in women, isleT-cell tumours, soft-tissue tumours (rare), metastases (breast, lung, melanoma, stomach, colon) (12 Dec 1998) |
| mammary neoplasms | Tumours of the mammary gland. Their occurrence is uncommon with the exception of the female dog, in which they account for 25% of all neoplasms. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|